Affinage · Plasmodium

PF3D7_0318600

cleavage and polyadenylation specificity factor, putative

Annotated
2026-09-07
2 papers in source corpus 2 papers cited in narrative 2 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PfCPSF3 (PF3D7_0318600) is a homologue of the mammalian CPSF-73 subunit that functions in pre-mRNA 3′-end processing in Plasmodium falciparum, and it is the direct molecular target of the antimalarial benzoxaborole AN3661 (PMID:28262680). In vitro resistance selection and CRISPR-Cas9 introduction of point mutations into pfcpsf3 both recapitulated AN3661 resistance, and homology modelling placed the resistance-conferring residues in the predicted AN3661-binding active site; AN3661 treatment caused loss of trophozoite-expressed transcripts consistent with inhibition of 3′-end processing, an effect abolished in resistant parasites (PMID:28262680). Beyond its role as an AN3661 target in pre-mRNA processing, the available corpus establishes only that PF3D7_0318600 was identified as a component of the PfCRL4 ubiquitin E3 ligase complex (which also contains PfCullin-2, PfRbx1, and WD40 repeat proteins) by immunoprecipitation, without direct functional characterization of this subunit within that complex (PMID:38416790).

Mechanistic history

Synthesis pass · year-by-year structured walk · 2 steps
  1. 2017 High

    It was unknown what protein mediated the antimalarial activity of the benzoxaborole AN3661; identifying PfCPSF3 as the direct target established both the drug's mechanism and a functional role for this protein in pre-mRNA 3′-end processing.

    Evidence In vitro resistance selection with CRISPR-Cas9 active-site mutagenesis, homology modelling, and transcript analysis in wild-type versus resistant parasites

    PMID:28262680

    Open questions at the time
    • No direct enzymatic reconstitution of PfCPSF3 endonuclease activity
    • Interaction with other CPSF subunits or the broader 3′-end processing machinery not mapped
    • AN3661 binding mode inferred from homology modelling rather than an experimental structure
  2. 2024 Low

    Whether PF3D7_0318600 participates in complexes beyond RNA processing was unaddressed; it was identified as a member of the PfCRL4 E3 ubiquitin ligase complex, hinting at a role outside canonical 3′-end processing.

    Evidence Immunoprecipitation and sequence analysis in P. falciparum

    PMID:38416790

    Open questions at the time
    • Single Co-IP without reciprocal validation or functional follow-up on this subunit
    • The functional contribution of PF3D7_0318600 within PfCRL4 is undefined
    • Relationship between the PfCRL4 association and the 3′-end processing role is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PfCPSF3 integrates a canonical pre-mRNA 3′-end processing function with membership in a CRL4-like ubiquitin ligase complex, and its direct catalytic mechanism, remain unresolved.
  • No experimental structure of PfCPSF3 or its AN3661 complex
  • Endonuclease activity not biochemically reconstituted
  • Functional role within PfCRL4 uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
PfCRL4 CRL4-like ubiquitin E3 ligase complex

Evidence

Reading pass · 2 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2017 PfCPSF3 (PF3D7_0318600), a homologue of mammalian CPSF subunit 3 (CPSF-73), is the direct target of the antimalarial benzoxaborole AN3661: in vitro resistance selection and CRISPR-Cas9 introduction of pfcpsf3 point mutations into parental lines both recapitulated AN3661 resistance, and homology modelling placed the resistance-conferring mutations in the active site where AN3661 is predicted to bind. AN3661 treatment caused loss of trophozoite-expressed transcripts, consistent with inhibition of pre-mRNA 3′-end processing, and this effect was absent in resistant parasites, establishing PfCPSF3 as the functional target. In vitro resistance selection, CRISPR-Cas9 active-site mutagenesis, homology modelling, transcript analysis in wild-type vs. resistant parasites Nature Communications High 28262680
2024 PF3D7_0318600 (cleavage and polyadenylation specificity factor subunit_A) was identified as a component of the PfCRL4 complex in P. falciparum by immunoprecipitation and sequence analysis; the complex also contains PfCullin-2, PfRbx1, and WD40 repeat proteins. Immunoprecipitation, sequence analysis PLoS Pathogens Low 38416790

Source papers

Stage 0 corpus · 2 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue. Nature communications 104 28262680
2024 Plasmodium falciparum contains functional SCF and CRL4 ubiquitin E3 ligases, and CRL4 is critical for cell division and membrane integrity. PLoS pathogens 12 38416790